Feeds:
Posts
Comments

Archive for the ‘Enlarged prostate’ Category

URO TODAY: Benign prostatic hyperplasia patients in whom prostate cancer is suspected and who have urination problems, with a previously negative biopsy result, can undergo transurethral resection of the prostate, which treats bladder outlet obstruction and gives early diagnosis of prostate cancer. READ MORE>

Read Full Post »

PHARMA TIMES: US regulators have approved GlaxoSmithKline’s combination drug, Jalyn, to treat symptomatic benign prostatic hyperplasia in men with an enlarged prostate. READ MORE>

Read Full Post »

DOMINION POST: A personal account of the problems caused by an enlarged prostate.

Read Full Post »

BIO-MEDICINE: Light Sciences Oncology Inc today announced the treatment of the first patients in a Phase 2 clinical trial of its innovative targeted drug treatment, Aptocine(TM) (talaporfin sodium), in benign prostatic hyperplasia.

Read Full Post »

JUNE 20: URO TODAY: Men undergoing surgical interventions for benign enlarged prostate are still at risk for subsequent development of prostate cancer due to residual tissue

Read Full Post »

MAY 26: TALES FROM SERENITY NOW HOSPITAL: How some US doctors learn to perform digital examinations on patients – a bizarre tale.

Read Full Post »

Dutasteride (Avodart), a commonly prescribed drug to treat benign prostatic hyperplasia, has been shown to lower the risk of prostate cancer by 23 percent in men with an increased risk of the disease.

Read Full Post »

Follow

Get every new post delivered to your Inbox.